[1] 信丰智,范建高. 欧洲非酒精性脂肪性肝病诊疗指南简介. 实用肝脏病杂志,2016,19(4):ⅤⅡ-ⅤⅢ. [2] Cohen JC,Horton JD,Hobbs HH.Human fatty liver disease:Old questions and new insights. Science,2011,332(6037):1519-1523. [3] 中华医学会肝病学分会脂肪肝和酒精性肝病组学.非酒精性脂肪性肝病诊疗指南(2010年修订版). 中华肝脏病杂志,2010,18(3):167-170. [4] Fan JG,Farrell GC.Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol,2009,50(1):204-210. [5] Angulo P.GI epidemiology:nonalcoholic fatty liver disease. Aliment Pharmacol Ther,2007,25(8):883-889. [6] Targher E,Giovanni H,Byrne J,et al.Non-alcoholic fatty liver disease and risk of incident cardiovascular disease:a meta-analysis. J Hepatol,2016,65(3):589-600. [7] Armstrong MJ,Adams LA,Canbay A,et al.Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology,2014,59(3):1174-1197. [8] Kim D,Choi SY,Park EH,et al.Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology,2012,56(2):605-613. [9] Lee YJ,Shim JY,Moon BS,et al.The relationship between arterial stiffness and nonalcoholic fatty liver disease. Dig Dis Sci,2012,57(1):196-203. [10] Myers RP,Pollett A,Kirsch R,et al.Controlled attenuation parameter(CAP):a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int,2012,32(6):902-910. [11] Zheng RD,Chen ZR,Chen JN,et al.Role of body mass index, waist-to-height and waist-to-hip ratio in prediction of nonalcoholic fatty liver disease. Gastroenterol Res Pract,2012,2012(2):362147. [12] 杨炯贤,陈伟,刘静民,等. 应用同位素稀释法验证生物电阻抗分析法测定人体成分的研究.肠内与肠外营养,2014,21(3):151-154. [13] So WY,Swearingin B,Crooms B,et al.Body composition measurements determined by air displacement plethysmography and eight-polar bioelectrical impedance analysis are equivalent in African American college students. Health Med,2012,6(6):1896-1899. [14] Targher G,Lonardo A,Rossini M. Nonalcoholic fatty liver disease and decreased bone mineral density:is there a link J Endocrinol Investig,2015,38(8):817-825. [15] Li M,Xu Y,Xu M,et al.Association between nonalcoholic fatty liver disease(NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. J Clin Endocrinol Metab,2012,97(6):2033-2038. [16] Lafortuna CL,Maffiuletti NA,Agosti F,et al.Gender variations of body composition,muscle strength and power output in morbid obesity. Int J Obes,2005,29(7):833-841. [17] Kanwal F,Kramer JR,Duan ZG,et al.Trends in the burden of non-alcoholic fatty liver disease in a US cohort of veterans. Clin Gastroenterol Hepatol,2016,14(2):301-308. [18] Kyle UG,Genton L,Gremion G,et al.Aging, physical activity and height-normalized body composition parameters,Clin Nutr,2004,23(1):79-88. [19] Younossi ZM,Otgonsuren M,Henry L,et al.Association of nonalcoholic fatty liver disease(NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009. Hepatology,2015,62(6):1723-1730. [20] Zhou YJ,Li YY,Nie YQ,et al.Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol,2007,13(47):6419-6424. |